Tuberculosis and Respiratory Diseases

Original Article

COPD

An Open-Label, Multicentre, Observational, Post-Marketing Study to Monitor the Safety and Effectiveness of Umeclidinium/Vilanterol in Korean Patients

Eun-Yeong Cho, Jung-Eun Cho, Eun-Bin Lee, et al.

Tuberc Respir Dis. 2023;86(1):33-46. Published online November 28, 2022

Background: Umeclidinium/vilanterol (UMEC/VI; ANORO ELLIPTA, GSK) is a commonly used dual bronchodilator. This study evaluated the safety and effectiveness of UMEC/VI in Korean patients with chronic obstructive pulmonary disease (COPD) over a 6-year period. Methods: This was an open-label, multicentre, observational, post-marketing surveillance study. A total of 3,375 patients were enrolled consecutively in 52 hospitals, by 53 physicians, between July 2014...

DOI: https://doi.org/10.4046/trd.2022.0055

Original Article

Tuberculosis

Isolation and Antimicrobial Susceptibility of Nontuberculous Mycobacteria in a Tertiary Hospital in Korea, 2016 to 2020

Keun Ju Kim, Seung-Hwan Oh, Doosoo Jeon, et al.

Tuberc Respir Dis. 2023;86(1):47-56. Published online December 8, 2022

Background: There is a global increase in isolation of nontuberculous mycobacteria (NTM). The aim of the study was to analyze longitudinal trends of NTM identification and pattern of antimicrobial susceptibility testing. Methods: NTM recovery rates, distribution of NTM species identification, and antimicrobial susceptibility pattern of NTM at Pusan National University Yangsan Hospital between January 2016 and December 2020 were retrospectively analyzed. Results:...

DOI: https://doi.org/10.4046/trd.2022.0115

Current Issue: Volume 86(1); Jan 2023

Original Articles

A Critical Systematic Review for Inhaled Corticosteroids on Lung Cancer Incidence: Not Yet Concluded Story: Suh-Young Lee, Soon Ho Yoon, Hyunsook Hong; Received June 30, 2022 Accepted December 27, 2022 Published online January 3, 2023; DOI: https://doi.org/10.4046/trd.2022.0084 [Epub ahead of print]; PDF

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184

MOST VIEWED MOST CITED

10,004	The Long-term Efficacy of Domiciliary Noninvasive Positive-Pressure Ventilation in Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Controlled Trials
6,707	Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
12,378	Revised Korean Cough Guidelines, 2020: Recommendations and Summary Statements
6,189	Role of Nuclear Factor Erythroid 2-Related Factor 2 in Chronic Obstructive Pulmonary Disease
4,265	Respiratory Reviews in Asthma 2022

+more

Cited By 15	COVID-19 Death and BCG Vaccination Programs Worldwide
Cited By 12	Recent Trends of Lung Cancer in Korea
Cited By 9	Are Patients with Asthma and Chronic Obstructive Pulmonary Disease Preferred Targets of COVID-19?
Cited By 9	The Association between Mortality and the Oxygen Saturation and Fraction of Inhaled Oxygen in Patients Requiring Oxygen Therapy due to COVID-19–Associated Pneumonia
Cited By 7	Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Comparison of Pre- and Post-Public–Private Mix Periods

+more

ABOUT

ARTICLE & TOPICS

Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES

FOR CONTRIBUTORS

Editorial Office: 101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347 Fax: +82-2-572-6683 E-mail: katrdsubmit@lungkorea.org